Hôpital Universitaire Sahloul
17
1
2
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Artificial Intelligence Algorithm for the Interpretation of Traumatic Bone Radiographs
Role: lead
Evaluation of the Effectiveness of the CardioStory Device in Distinguishing Heart Failure From Other Causes in Patients Presenting With Dyspnea
Role: lead
Monocyte Distribution Width (MDW): An Early Marker of Sepsis in Patients With Comorbidities
Role: lead
External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population
Role: lead
Validation of a New Score for UGI Bleeding in the ED: the Study of the TU-GIB Score
Role: lead
Quercetin In The Treatment Of SARS-COV 2
Role: lead
Detection Dogs as a Help in the Detection of COVID-19
Role: lead
Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness
Role: lead
The Efficacy of a Herbal Supplement in the Prevention of PTSD
Role: lead
Clinical-biological Score for Upper Gastrointestinal Bleeding
Role: lead
The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)
Role: lead
Triage Score VS Quick-Sofa Score in Septic Patients in the Emergency Department
Role: lead
Nigella 5 in the Treatment of SARS COV2 (COVID-19)
Role: lead
Nigelle 5 in Prevention of Influanza
Role: lead
Non-invasive Tool for Measuring Hemoglobin in Severe Trauma Patients in the ED
Role: lead
Colloidal Silver, Treatment of COVID-19
Role: lead
Incidence Study on Acute Coronary Disease With ST Segment Elevation
Role: lead
All 17 trials loaded